SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudeep Pharma informs about newspaper publication

20 Dec 2025 Evaluate

With reference to its Letter dated 19th December 2025 vide which the company has submitted the Un-audited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter and Six Months period ended 30th September 2025 (2025-26), Sudeep Pharma has submitted copies of the Extract of Un-audited Financial Results of the Company for the Second Quarter and Six Months period ended September 30, 2025, on Consolidated basis, published in Business Standard, English language newspaper and Vadodara Samachar, Regional language newspaper at Vadodara, Gujarat on 20th December 2025. The above information is also available on the Company’s website at https://www.sudeeppharma.com/.

The above information is a part of company’s filings submitted to BSE.

Sudeep Pharma Share Price

610.30 -3.45 (-0.56%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×